Allergan, Sosei suspend clinical development of dementia drug
admin 18th September 2018 Uncategorised 0Allergan and Sosei are voluntarily suspending clinical development activities with HTL0018318 pending investigation of an unexpected toxicology finding in an animal study involving non-human primates.
More: Allergan, Sosei suspend clinical development of dementia drug
Source: News